125 related articles for article (PubMed ID: 10047687)
1. [Erosive duodenitis after eradication therapy for Helicobacter pylori].
Goto T; Hisiki S; Tanaka M; Siwa T; Tochikubo O; Kawaguchi Y; Yokoyama N; Komatu K; Suzuki R
Nihon Shokakibyo Gakkai Zasshi; 1999 Jan; 96(1):14-20. PubMed ID: 10047687
[TBL] [Abstract][Full Text] [Related]
2. [Changes in serum anti-Helicobacter pylori IgG antibody, pepsinogen I, and pepsinogen II after eradication therapy of Helicobacter pylori].
Ando H; Kagaya T; Takemori Y; Noda Y
Nihon Shokakibyo Gakkai Zasshi; 1997 Nov; 94(11):723-9. PubMed ID: 9396326
[TBL] [Abstract][Full Text] [Related]
3. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Sugiyama T; Kato M; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S
Helicobacter; 2001 Sep; 6(3):254-61. PubMed ID: 11683930
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori eradication--comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis.
Tan WC; Hogan J; Purkayastha SK; Lombard M; Krasner N
Int J Clin Pract; 1997 Jun; 51(4):214-6. PubMed ID: 9287260
[TBL] [Abstract][Full Text] [Related]
6. Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease.
Lo WC; Lin HJ; Wang K; Perng CL; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Mar; 59(3):171-6. PubMed ID: 9198292
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of perforated gastroduodenal ulcer by simple suture followed by Helicobacter pylori eradication].
Tran TT; Quandalle P
Ann Chir; 2002 Jan; 127(1):32-4. PubMed ID: 11833303
[TBL] [Abstract][Full Text] [Related]
8. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
9. De novo erosive esophagitis in duodenal ulcer patients related to pre-existing reflux symptoms, smoking, and patient age, but not to Helicobacter pylori eradication: a one-year follow-up study.
Jonaitis L; Kupčinskas J; Kiudelis G; Kupčinskas L
Medicina (Kaunas); 2010; 46(7):454-9. PubMed ID: 20966617
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of the triple therapy in the eradication of H. pylori in peptic ulcer].
Boixeda de Miquel D
Rev Esp Enferm Dig; 1997 Dec; 89(12):875-7. PubMed ID: 9494374
[No Abstract] [Full Text] [Related]
11. Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin.
Isomoto H; Furusu H; Ohnita K; Wen CY; Inoue K; Kohno S
World J Gastroenterol; 2005 Mar; 11(11):1629-33. PubMed ID: 15786539
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
Andreev DN; Maev IV; Dicheva DT; Samsonov AA; Partzvania-Vinogradova EV
Ter Arkh; 2018 Aug; 90(8):27-32. PubMed ID: 30701936
[TBL] [Abstract][Full Text] [Related]
13. Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori.
Sieg A; Sellinger M; Schlauch D; Hörner M; Fuchs W
Aliment Pharmacol Ther; 1999 Jul; 13(7):865-8. PubMed ID: 10383519
[TBL] [Abstract][Full Text] [Related]
14. The effect of Helicobacter pylori eradication on duodenal gastric metaplasia.
Uygun A; Kadayifci A; Demiriz M; Erdil A; Gulsen M; Baggi S; Karaeren N; Dagalp K
J Int Med Res; 1999; 27(4):159-66. PubMed ID: 10599027
[TBL] [Abstract][Full Text] [Related]
15. Omeprazole-based dual and triple therapy for the treatment of Helicobacter pylori infection in peptic ulcer disease: a randomized trial.
Pieramico O; Zanetti MV; Innerhofer M; Malfertheiner P
Helicobacter; 1997 Jun; 2(2):92-7. PubMed ID: 9432335
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease.
Liou JM; Chen CY; Wu MS; Hsu MT; Fang CC; Lin YL; Chang MC; Lin JT; Wang HP
Hepatogastroenterology; 2006; 53(71):792-6. PubMed ID: 17086891
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of the dosing regimen of pantoprazole 40 mg, amoxicillin 1000 mg and clarithromycin 500 mg, twice daily for 7 days, in the eradication of Helicobacter pylori in patients with peptic ulcer].
Coelho LG; Mattos AA; Francisconi CF; Castro Lde P; André SB
Arq Gastroenterol; 2004; 41(1):71-6. PubMed ID: 15499429
[TBL] [Abstract][Full Text] [Related]
18. Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin and clarithromycin.
Schütze K; Hentschel E
Z Gastroenterol; 1995 Nov; 33(11):651-3. PubMed ID: 8600661
[TBL] [Abstract][Full Text] [Related]
19. [Four kinds of new triple therapy regiments for Helicobacter pylori eradication in patients with peptic ulcer].
Shirai T; Kurumada T; Kouda K; Watanabe S; Tada U; Wada T; Takagi A; Harasawa S; Miwa T
Nihon Rinsho; 1999 Jan; 57(1):140-3. PubMed ID: 10036951
[No Abstract] [Full Text] [Related]
20. Neither genotype nor the gastric colonization site of Helicobacter pylori are predictive factors for the development of erosive esophagitis in patients with peptic ulcer disease, 1 year after eradication.
Batista CA; Silva FM; Barbuti RC; Eisig JN; Mattar R; Navarro-Rodriguez T
Arq Gastroenterol; 2009; 46(3):204-8. PubMed ID: 19918687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
